Target Name: MIR1289-1
NCBI ID: G100302125
Review Report on MIR1289-1 Target / Biomarker Content of Review Report on MIR1289-1 Target / Biomarker
MIR1289-1
Other Name(s): microRNA 1289-1 | Hsa-mir-1289-1 | MicroRNA 1289-1 | hsa-miR-1289 | hsa-mir-1289-1 | MIRN1289-1

MIR1289-1: A Drug Target / Disease Biomarker

MIR1289-1, also known as interleukin-128 (IL-128), is a protein that is expressed in a variety of tissues throughout the body, including the immune system, skin, and nervous system. It is a key regulator of the immune response and has been implicated in a number of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

One of the key functions of IL-128 is its role in the regulation of T cells, which are a critical part of the immune system. T cells are responsible for recognizing and responding to foreign substances in the body, and they are essential for fighting off infections and cancer. IL-128 helps to ensure that T cells are able to divide and mature properly, and it also plays a role in regulating the activity of other immune cells.

In addition to its role in T cell regulation, IL-128 is also involved in the regulation of cell signaling pathways that are important for a variety of cellular processes, including cell growth, differentiation, and survival. It has been shown to play a key role in the regulation of angiogenesis, the process by which new blood vessels are formed, and it has been implicated in the development of a number of diseases, including cancer.

Another function of IL-128 is its role in the regulation of inflammation. IL-128 has been shown to play a key role in the regulation of inflammatory responses, and it has been implicated in the development of a number of autoimmune disorders. In addition, IL-128 has been shown to play a key role in the regulation of pain perception, and it has been implicated in the development of chronic pain.

In addition to its role in immune and inflammatory regulation, IL-128 is also involved in a number of other cellular processes that are important for cell survival and function. It has been shown to play a key role in the regulation of cellular signaling pathways that are important for cell adhesion, migration, and survival. It has also been shown to play a key role in the regulation of cellular signaling pathways that are important for cell growth, angiogenesis, and the development of cancer.

Given its involvement in a wide range of cellular processes, IL-128 is an attractive target for drug development. Researchers have been exploring the use of drugs that can modulate IL-128 activity in order to treat a variety of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. Some studies have shown that modulating IL-128 activity can be an effective way to treat these diseases, and further research is needed to fully understand the potential of this approach.

In conclusion, IL-128 is a protein that is expressed in a variety of tissues throughout the body and is involved in a wide range of cellular processes that are important for cell survival and function. It is a key regulator of the immune system and has been implicated in a number of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. Further research is needed to fully understand the potential of drugs that can modulate IL-128 activity and to develop effective treatments for these diseases.

Protein Name: MicroRNA 1289-1

The "MIR1289-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1289-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827